SLE Clinical Trials

69 clinical trials for SLE across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease — RECRUITING · PHASE1
• A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. — RECRUITING · PHASE1
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — RECRUITING · PHASE2
• Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA — RECRUITING · PHASE1
• CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus — RECRUITING · PHASE1
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus — RECRUITING
• A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. — RECRUITING · PHASE1
• Safety and Efficacy of ONT01 in Lupus — RECRUITING · PHASE1
• UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients — RECRUITING · PHASE1
• Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases — RECRUITING · PHASE4
• Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease — RECRUITING · PHASE1
• Argentinian Prospective Registry of Patients With Lupus — RECRUITING
• National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia — RECRUITING
• Uromodulin as a Biomarker in Lupus Nephritis — NOT_YET_RECRUITING
• Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus — ACTIVE_NOT_RECRUITING · PHASE2
• A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus — COMPLETED · PHASE1
• Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases — ACTIVE_NOT_RECRUITING · NA
• JBT-101 in Systemic Lupus Erythematosus (SLE) — COMPLETED · PHASE2
• First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics — NOT_YET_RECRUITING · PHASE1
• Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus. — COMPLETED · PHASE1
• A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain — ACTIVE_NOT_RECRUITING · NA
• A Study of RD06-04 in Patients With Active Autoimmune Diseases — WITHDRAWN · PHASE1
• Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus — NOT_YET_RECRUITING · PHASE1
• Myocardial Inflammation in Systemic Lupus Erythematosus — ACTIVE_NOT_RECRUITING
• AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus — ACTIVE_NOT_RECRUITING · PHASE1
• Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) — ACTIVE_NOT_RECRUITING · PHASE1
• Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus — NOT_YET_RECRUITING
• SLE Severity Linked to Vitamin D Via Treg Cells in Pediatric Patients — COMPLETED
• Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia — NOT_YET_RECRUITING · PHASE2
• Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) — TERMINATED
• Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients — COMPLETED · PHASE4
• Improving the Assessment of SLE Disease Activity — COMPLETED
• Assessment of Blood Indices in Systemic Lupus Erythematosus — NOT_YET_RECRUITING
• Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers — NOT_YET_RECRUITING
• Phase 1b/2a in SLE With Budoputug — WITHDRAWN · PHASE1
• Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity — NOT_YET_RECRUITING
• Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients — COMPLETED · NA
• Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus — COMPLETED
• Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients — OTHER
• Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women — OTHER
• Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE — OTHER
• COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases — COMPLETED · PHASE3
• BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus — COMPLETED
• Does Balnotherapy Influence the Qualitiy of Life in SLE — COMPLETED · NA
• Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus. — OTHER
• Flow Mediated Dilation in Association With Hyperuricemia — OTHER
• Choosing Tests Wisely in Rheumatology — COMPLETED · NA

Refine this search